Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Trial of Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China

NCT02647554 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT02647554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02647554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled, Trial of Ulinastatin Treatment in Adult Patients With Sepsis and Septic Shock in China
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2016
Completion date
August 1, 2021
Enrollment
347 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock